Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP671117.RAmLAEOHf29e0HQcnOVCVRod8WkiQZnxYdTB5C-_WQLp0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP671117.RAmLAEOHf29e0HQcnOVCVRod8WkiQZnxYdTB5C-_WQLp0130_assertion type Assertion NP671117.RAmLAEOHf29e0HQcnOVCVRod8WkiQZnxYdTB5C-_WQLp0130_head.
- NP671117.RAmLAEOHf29e0HQcnOVCVRod8WkiQZnxYdTB5C-_WQLp0130_assertion description "[Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671117.RAmLAEOHf29e0HQcnOVCVRod8WkiQZnxYdTB5C-_WQLp0130_provenance.
- NP671117.RAmLAEOHf29e0HQcnOVCVRod8WkiQZnxYdTB5C-_WQLp0130_assertion evidence source_evidence_literature NP671117.RAmLAEOHf29e0HQcnOVCVRod8WkiQZnxYdTB5C-_WQLp0130_provenance.
- NP671117.RAmLAEOHf29e0HQcnOVCVRod8WkiQZnxYdTB5C-_WQLp0130_assertion SIO_000772 17189407 NP671117.RAmLAEOHf29e0HQcnOVCVRod8WkiQZnxYdTB5C-_WQLp0130_provenance.
- NP671117.RAmLAEOHf29e0HQcnOVCVRod8WkiQZnxYdTB5C-_WQLp0130_assertion wasDerivedFrom befree-20140225 NP671117.RAmLAEOHf29e0HQcnOVCVRod8WkiQZnxYdTB5C-_WQLp0130_provenance.
- NP671117.RAmLAEOHf29e0HQcnOVCVRod8WkiQZnxYdTB5C-_WQLp0130_assertion wasGeneratedBy ECO_0000203 NP671117.RAmLAEOHf29e0HQcnOVCVRod8WkiQZnxYdTB5C-_WQLp0130_provenance.